newsfilter
← Latest News
GlobeNewswire·

Bio-Path Holdings Provides 2024 Clinical and Operational Update

HOUSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio